cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Abcellera Biologics Inc
42 own
33 watching
Current Price
$10.76
$0.24
(2.28%)
logo-abcl
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
3,074.79M
52-Week High
52-Week High
14.97
52-Week Low
52-Week Low
5.42
Average Volume
Average Volume
1.25M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization3,074.79M
icon52-Week High14.97
icon52-Week Low5.42
iconAverage Volume1.25M
iconDividend Yield--
iconP/E Ratio--
What does the Abcellera Biologics Inc do?
Our mission is to improve health with technologies that transform the way that antibody-based therapies are discovered. We aim to become the centralized operating system for next generation antibody discovery. Our full-stack, artificial intelligence-, or AI, powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. --- We were incorporated in 2012 under the Business Corporations Act (British Columbia), or the BCBCA. Our principal executive offices are located at 2215 Yukon Street Vancouver, British Columbia, V5Y 0A1, Canada and our telephone number is (604) 559-9005. We have six wholly owned subsidiaries, Lineage, a Delaware corporation, Trianni, a California corporation, AbCellera US Holdings Inc., a Delaware corporation, AbCellera Properties Inc., a BCBCA company, AbCellera Properties Columbia Inc., a BCBCA company, and Channel Biologics Pty Ltd., a proprietary company registered in New South Wales, Australia. Our website address is www.abcellera.com.
Read More
How much money does Abcellera Biologics Inc make?
News & Events about Abcellera Biologics Inc.
Ticker Report
23days ago
AbCellera Biologics Inc. (NASDAQ:ABCL Get Rating) was the recipient of a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 15,350,000 shares, a decline of 7.0% from the November 30th total of 16,510,000 shares. ...
Business Wire
1month ago
AbCellera (Nasdaq: ABCL) and Rallybio Corporation (Nasdaq: RLYB) announced today that they have entered into a strategic alliance to discover, develop, and commercialize novel antibody-based therapeutics for rare diseases. This multi-year, multi-target collaboration will combine AbCelleras antibody...
Business Wire
2 months ago
AbCellera (Nasdaq: ABCL) today announced the release of new data on its T-cell engager (TCE) platform at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, to be held virtually and at the Boston Convention & Exhibition Center from November 8 to 12, 2022. AbCelleras poster...
Business Wire
2 months ago
AbCellera (Nasdaq: ABCL) announced today that Regeneron has elected to exercise its right to advance a therapeutic antibody candidate, discovered in partnership with AbCellera as part of a multi-target collaboration between the companies, into further preclinical development. The partnership, which...
Business Wire
7 months ago
AbCellera (Nasdaq: ABCL) today announced that Eli Lilly and Company (Lilly) has entered into a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab, the second antibody developed through AbCelleras collaboration with Lilly, for approximately...
Frequently Asked Questions
Frequently Asked Questions
What is Abcellera Biologics Inc share price today?
plus_minus_icon
Can Indians buy Abcellera Biologics Inc shares?
plus_minus_icon
How can I buy Abcellera Biologics Inc shares from India?
plus_minus_icon
Can Fractional shares of Abcellera Biologics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Abcellera Biologics Inc stocks?
plus_minus_icon
What is today’s traded volume of Abcellera Biologics Inc?
plus_minus_icon
What is today’s market capitalisation of Abcellera Biologics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Abcellera Biologics Inc?
plus_minus_icon
What percentage is Abcellera Biologics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Abcellera Biologics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$10.76
$0.24
(2.28%)
logo-abcl
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00